Last reviewed · How we verify
NCT04146961
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
trial testing Alcon PanOptix or PanOptix Toric IOL in Cataract Surgery in 59 participants. Completed in 21 July 2020.
10 April 2020
Quick facts
| Lead sponsor | Research Insight LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 59 |
| Start date | 5 October 2019 |
| Primary completion | 10 April 2020 |
| Estimated completion | 21 July 2020 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Alcon PanOptix or PanOptix Toric IOL
Conditions studied
- Cataract Surgery — all drugs for Cataract Surgery →
Sponsor
Research Insight LLC — full company profile →
Who can join
Eligibility, any sex, with Cataract Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04146961
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract Surgery
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07108192 — The Effect of Hand Holding and Stress Ball Intervention on Pain and Anxiety · NA · recruiting
- NCT07452770 — Stress Ball Use During Cataract Surgery: Effects on Pain, Fear and Satisfaction · NA · recruiting
- NCT07178639 — Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery · NA · recruiting
- NCT07000669 — Bilateral Peribulbar Block for Cataract Surgery · recruiting
Other Research Insight LLC trials
Trials by the same sponsor.
- NCT07276802 — The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) · Phase 4 · not yet recruiting
- NCT07144644 — 2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings · completed
- NCT06482164 — The THINK Study Incidence of Neurotrophic Keratopathy) · NA · completed
- NCT06482177 — The COAT Trial: Cequa's Onset of Action Trial · Phase 4 · completed
- NCT05346172 — The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04146961 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Research Insight LLC
- Last refreshed: 30 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04146961.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing